Eagle Pharmaceuticals Announces CFO Transition and Leadership Changes
Company Announcements

Eagle Pharmaceuticals Announces CFO Transition and Leadership Changes

Eagle Pharmaceuticals Inc (EGRX) has shared an update.

Brian Cahill stepped down as CFO of Eagle Pharmaceuticals, and Steven Ratoff, a Board member, was appointed as the Interim CFO. Ratoff brings a wealth of experience from various leadership roles, including CEO positions at specialty pharmaceutical companies. The company is compensating Cahill for his continued consulting services during a six-month transition period. Meanwhile, Ratoff’s interim position comes with a defined compensation structure, but excludes him from the company’s executive bonus and severance plans. Additionally, the company has discontinued the consulting services of its former CEO, Scott Tarriff.

See more data about EGRX stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskEagle Pharmaceuticals Appoints New CFO Amid Leadership Change
TheFlyEagle Pharmaceuticals appoints Christopher Krawtschuk as CFO
TipRanks Auto-Generated NewsdeskEagle Pharmaceuticals Implements Stockholder Rights Plan
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App